This site is still under development. Information, features, and some organizational
aspects of the data still need further work and will change as we continue building.

Biomarker

Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.

What Biomarkers Mean in Everyday Medical Language

A biomarker is a biological molecule found in blood, other body fluids, or tissues that acts as a sign of a normal or abnormal process, condition, or disease. These molecules can be proteins, genes, or other substances that give clues about what is happening inside the body. In simple terms, biomarkers are measurable signs that help doctors understand health or illness.

Why Biomarkers Matter in Cancer Care

In cancer care, biomarkers are especially important because they reveal unique features of a person’s cancer. Each cancer can have different changes in its genes or proteins, which affect how the cancer grows and responds to treatment. Biomarker testing looks for these changes and helps guide treatment decisions. For example, some cancer medicines, called targeted therapies or immunotherapies, work best only if certain biomarkers are present. Knowing whether these biomarkers exist can help doctors choose treatments more likely to help and avoid those that may not work.

What Patients Might See or Hear About Biomarkers

Patients may hear about biomarker testing when doctors discuss tumor testing, tumor profiling, or genetic testing of the cancer. This testing involves analyzing a sample of the tumor or blood to find specific changes. Results may appear in pathology reports, treatment plans, or clinical trial information. Sometimes biomarker tests are called companion diagnostic tests because they are linked to a particular treatment. It is important to understand that biomarker testing looks at changes in the cancer cells themselves, not inherited genetic risks passed down from parents.

How Biomarkers Are Used in Cancer Care

Doctors use biomarkers during diagnosis, to help stage cancer, to monitor how well treatment is working, and to plan follow-up care. Biomarker testing can also help identify clinical trials that match a patient’s cancer profile, offering access to new treatments. While having a biomarker does not guarantee a treatment will work, it can increase the chances of success. Biomarker testing is part of precision medicine, which aims to tailor treatment to the individual characteristics of each person’s cancer.

Common Questions and Understanding Biomarker Results

Because biomarker testing involves many different molecules and tests, it can be confusing. Patients may wonder what their specific biomarker results mean for their care. It is helpful to ask your care team questions such as: What biomarkers were tested? How do these results affect my treatment options? Are there clinical trials I might be eligible for based on my biomarker results? Understanding biomarker information in context is key. It is one piece of the overall diagnosis and treatment plan, not a standalone answer.

Important Notes About Biomarker Testing

Biomarker testing is different from genetic testing that looks for inherited mutations that increase cancer risk. Biomarker testing focuses on changes in the cancer cells themselves, which develop during a person’s life. Also, biomarker testing results do not guarantee a particular treatment will work but help guide decisions. The testing is one tool among many that doctors use to plan care.

Next Steps for Patients

If you hear about biomarkers in your care, the next step is to discuss with your doctor or nurse what the testing means for you. They can explain how biomarker results fit into your treatment plan and what options are available. Learning about biomarkers can help you feel more informed and involved in decisions about your cancer care.

Sources

Public source information used for this glossary entry includes: